Stock Events

Stock Events

Tarsus Pharmaceuticals (TARS) Q1 2026 Earnings

23FebConfirmed

Q2 2025

Q3 2025

Q4 2025

Q1 2026

-0.73

-0.52

-0.31

-0.09

Details

Expected EPS

-0.092975

Actual EPS

-0.2

Surprise EPS

-0.11

Surprise Percent

+115.11%

Description

Tarsus Pharmaceuticals (TARS) has reported earnings of -0.2 per share for Q1 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.